In a breakthrough for global child health, Swiss authorities have approved Coartem Baby. Researchers have developed the first-ever medicine specifically designed to treat malaria in infants weighing less than five kilograms. The announcement by pharmaceutical giant Novartis marks a pivotal moment in the fight against a disease that disproportionately affects the youngest and most vulnerable. The new treatment addresses a…